PCMU
MRK icon

Paragon Capital Management (Utah)’s Merck MRK Stock Holding History

Paragon Capital Management (Utah)’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,373
Closed -$1.62M – 82
2025
Q4 		$1.62M Sell
15,373
-1,836
-11% -$172K 1.25% 25
2025
Q3 		$1.44M Sell
17,209
-654
-4% -$53.9K 1.08% 29
2025
Q2 		$1.41M Sell
17,863
-125
-0.7% -$9.94K 1.08% 37
2025
Q1 		$1.61M Buy
17,988
+3,013
+20% +$281K 1.3% 19
2024
Q4 		$1.49M Buy
+14,975
New +$1.54M 1.16% 35

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Paragon Capital Management (Utah)'s MRK Position: Q1 2026 in Review

Paragon Capital Management (Utah) sold out of Merck (MRK) in Q1 2026, closing a stake of 15,373 shares — an estimated $1.62M sold.

Paragon Capital Management (Utah) first reported a position in MRK in Q4 2024 and held it in 5 quarters. The position peaked at $1.62M in Q4 2025. 3,783 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Paragon Capital Management (Utah) reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Paragon Capital Management (Utah) sold 15,373 Merck shares in Q1 2026, an estimated $1.62M.
  • Paragon Capital Management (Utah) first reported a position in Merck in Q4 2024 and held it in 5 quarters.
  • Paragon Capital Management (Utah)'s Merck position peaked at $1.62M in Q4 2025.
  • 3,783 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Paragon Capital Management (Utah)'s 13F filing for Q1 2026, filed 17 Apr 2026.